New Edge Advisors, LLC Novo Nordisk A S Transaction History

New Edge Advisors, LLC

$11.2 Billion
Q1 2024

A detailed history of New Edge Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, New Edge Advisors, LLC holds 89,691 shares of NVO stock, worth $12.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

89,691

Previous 72,301 24.05%

Holding current value

$12.1 Million

Previous $7.48 Million 53.98%

% of portfolio

0.1%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $1.78 Million - $2.36 Million	17,390 Added 24.05%	89,691 $11.5 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $1.84 Million - $2.21 Million	21,003 Added 40.94%	72,301 $7.48 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $2.7 Million - $5.93 Million	29,695 Added 137.46%	51,298 $4.67 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.49 Million - $1.65 Million	9,550 Added 79.23%	21,603 $3.5 Million
Q1 2023 May 12, 2023	SELL	$132.34 - $159.14 $215,978 - $259,716	-1,632 Reduced 11.93%	12,053 $1.92 Million

Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $164,285 - $216,798	1,602 Added 13.26%	13,685 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $74,223 - $91,088	-779 Reduced 6.06%	12,083 $1.2 Million
Q2 2022 Aug 09, 2022	SELL	$103.24 - $121.81 $997,298 - $1.18 Million	-9,660 Reduced 42.89%	12,862 $1.43 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $62,842 - $75,964	-675 Reduced 2.91%	22,522 $2.5 Million
Q4 2021 Feb 17, 2022	BUY	$95.88 - $117.08 $966,182 - $1.18 Million	10,077 Added 76.81%	23,197 $2.6 Million
Q3 2021 Oct 29, 2021	SELL	$84.42 - $106.62 $99,784 - $126,024	-1,182 Reduced 8.26%	13,120 $1.26 Million
Q2 2021 Jul 22, 2021	BUY	$67.66 - $84.76 $94,791 - $118,748	1,401 Added 10.86%	14,302 $1.2 Million
Q1 2021 Apr 26, 2021	BUY	$67.06 - $75.82 $646,860 - $731,359	9,646 Added 296.34%	12,901 $870,000
Q3 2020 Nov 03, 2020	SELL	$63.69 - $70.22 $6,878 - $7,583	-108 Reduced 3.21%	3,255 $226,000
Q2 2020 Jul 29, 2020	BUY	$58.54 - $67.94 $196,870 - $228,482	3,363 New	3,363 $220,000
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $3,333 - $3,986	-81 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	81	81 $0

Others Institutions Holding NVO

# of Institutions

1,851

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $305B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Novo Nordisk A S Transaction History